Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 11Breast Neoplasms 11Obesity 8Motor Activity 7Malnutrition 6Lung Neoplasms 6Prostatic Neoplasms 5Overweight 5Colorectal Neoplasms 5Weight Loss 4Hypertension 4Stroke 3Stomach Neoplasms 3Pancreatic Neoplasms 3Heart Failure 3Diabetes Mellitus 3Cardiovascular Diseases 3Sarcopenia 2Polycystic Ovary Syndrome 2Osteoporosis 2Kidney Diseases 2Inflammation 2Heart Diseases 2Gastrointestinal Neoplasms 2Frailty 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cachexia 2Arthritis 2

Interventions

Paclitaxel 114Carboplatin 114Cisplatin 45Topotecan 43Gemcitabine 31Cyclophosphamide 31Docetaxel 28liposomal doxorubicin 27Bevacizumab 27Filgrastim 20pembrolizumab 19Peripheral Blood Stem Cell Transplantation 18Taxes 15Drug Therapy 15sargramostim 12Hyperthermic Intraperitoneal Chemotherapy 12olaparib 11Chemotherapy, Adjuvant 10Surgical Procedures, Operative 9Etoposide 9oregovomab 8mirvetuximab soravtansine 8Nivolumab 8Amifostine 8Therapeutics 7Melphalan 7Erlotinib Hydrochloride 7rucaparib 6aldesleukin 6Oxaliplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Ovarian Epithelial × Nutrition Assessment × Clear all
NCT01439659 2026-01-16

Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
75 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡